JP2007506801A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506801A5
JP2007506801A5 JP2006533141A JP2006533141A JP2007506801A5 JP 2007506801 A5 JP2007506801 A5 JP 2007506801A5 JP 2006533141 A JP2006533141 A JP 2006533141A JP 2006533141 A JP2006533141 A JP 2006533141A JP 2007506801 A5 JP2007506801 A5 JP 2007506801A5
Authority
JP
Japan
Prior art keywords
modafinil
composition
use according
agent
cisplatinum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006533141A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007506801A (ja
Filing date
Publication date
Priority claimed from US10/845,836 external-priority patent/US20040229943A1/en
Application filed filed Critical
Publication of JP2007506801A publication Critical patent/JP2007506801A/ja
Publication of JP2007506801A5 publication Critical patent/JP2007506801A5/ja
Withdrawn legal-status Critical Current

Links

JP2006533141A 2003-05-16 2004-05-17 モダフィニルおよび他の薬剤を含んでなる製薬学的組成物 Withdrawn JP2007506801A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47130203P 2003-05-16 2003-05-16
US10/845,836 US20040229943A1 (en) 2003-05-16 2004-05-14 Analeptic and drug combinations
PCT/US2004/015408 WO2004103359A1 (en) 2003-05-16 2004-05-17 Pharmaceutical combination comprising modafinil and another drug

Publications (2)

Publication Number Publication Date
JP2007506801A JP2007506801A (ja) 2007-03-22
JP2007506801A5 true JP2007506801A5 (enExample) 2007-06-28

Family

ID=33424098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006533141A Withdrawn JP2007506801A (ja) 2003-05-16 2004-05-17 モダフィニルおよび他の薬剤を含んでなる製薬学的組成物

Country Status (14)

Country Link
US (1) US20040229943A1 (enExample)
EP (1) EP1635807A1 (enExample)
JP (1) JP2007506801A (enExample)
KR (1) KR20060015727A (enExample)
AU (1) AU2004241110A1 (enExample)
BR (1) BRPI0411176A (enExample)
CA (1) CA2524870A1 (enExample)
EA (1) EA200501821A1 (enExample)
IS (1) IS8099A (enExample)
MX (1) MXPA05012358A (enExample)
MY (1) MY135829A (enExample)
NO (1) NO20055173L (enExample)
TW (1) TW200509896A (enExample)
WO (1) WO2004103359A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03000747A (es) * 2000-07-27 2003-06-04 Teva Pharma Modafinilo cristalino y puro y proceso para prepararlo.
US20070053976A1 (en) * 2002-05-17 2007-03-08 Eisai R & D Management Co., Ltd. Novel combination of drugs as antidepressant
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
WO2005099822A2 (en) * 2004-04-13 2005-10-27 Cephalon, Inc. Reduction of drug / drug interactions with modafinil
DE602007010595D1 (de) * 2006-03-23 2010-12-30 Yissum Res Dev Co Verwendung von digitalis-artigen verbindungen bei der behandlung von affektiven störungen
DE102006015734A1 (de) * 2006-04-04 2007-10-11 Hermann, Holger Lars, Dr. Kombinationspräparate aus Modafinil, Ritalin und Topiramat und deren Derivaten zur Behandlung von Kokainabhängigkeit und/oder Impulskontrollstörung
KR101408488B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 경시적인 변색을 억제하는 방법
JP5237112B2 (ja) * 2006-12-01 2013-07-17 日東電工株式会社 経皮吸収製剤
RU2483729C2 (ru) * 2008-05-30 2013-06-10 Нитто Денко Корпорейшн Чрескожно абсорбируемый препарат
EP2279739B2 (en) * 2008-05-30 2018-02-28 Nitto Denko Corporation Donepezil-containing patch preparation and packaging thereof
EP2521546A4 (en) * 2010-01-07 2013-06-26 Vivus Inc TREATMENT OF THE OBSTRUCTIVE SLEEP APNEO SYNDROME COMBINED WITH ANTIBODY ANTIBODY AND AN ADDITIONAL ACTIVE SUBSTANCE
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
JP2025513295A (ja) * 2022-04-21 2025-04-24 ゼブラ セラピューティクス, インコーポレイテッド ガンマ-ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696153A (en) * 1994-05-16 1997-12-09 Napro Biotherapeutics, Inc. Therapeutic regimen for treating patients
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6503950B1 (en) * 1999-08-23 2003-01-07 David M. Ockert Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos

Similar Documents

Publication Publication Date Title
JP2006515883A5 (enExample)
JP2015515475A5 (enExample)
JP2013518107A5 (enExample)
JP2021100937A5 (enExample)
JP2009539769A5 (enExample)
EP2248519A3 (en) Non-mucoadhesive film dosage forms
JP2019515908A5 (enExample)
DK1061915T3 (da) Farmaceutiske formuleringer af taxaner
JP2013527232A5 (enExample)
JP2013511507A5 (enExample)
JP2004155791A5 (enExample)
JP2016539156A5 (enExample)
BG66113B1 (bg) Комбиниран химиотерапевтичен състав
JP2009515901A5 (enExample)
JP2005508338A5 (enExample)
JP2007516193A5 (enExample)
JP2005538045A5 (enExample)
JP2009517411A5 (enExample)
JP2005508963A5 (enExample)
JP2001513506A5 (enExample)
JP2005530735A5 (enExample)
ATE303137T1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
JP2010500284A5 (enExample)
JP2011500589A5 (enExample)
JP2006503095A5 (enExample)